TIGIT and melanoma: It was found that IL-15 increased the expression of TIGIT and CD226 on TiNKs, augmented NK-cell-mediated melanoma cytotoxicity in vitro, and suppressed tumor metastasis in preclinical models together with TIGIT blockade [34, 154].